Avery W Catlin - Net Worth and Insider Trading
Avery W Catlin Net Worth
The estimated net worth of Avery W Catlin is at least $649,640 dollars as of 2024-04-20. Avery W Catlin is the Director of Provention Bio Inc and owns about 20,000 shares of Provention Bio Inc (PRVB) stock worth over $499,600. Avery W Catlin is the Sr. VP & CFO of Celldex Therapeutics Inc and owns about 2,341 shares of Celldex Therapeutics Inc (CLDX) stock worth over $88,911. Avery W Catlin is also the Director of Corbus Pharmaceuticals Holdings Inc and owns about 1,567 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) stock worth over $61,129. Details can be seen in Avery W Catlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Avery W Catlin has not made any transactions after 2018-12-26 and currently still holds the listed stock(s).
Transaction Summary of Avery W Catlin
Avery W Catlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Avery W Catlin owns 3 companies in total, including Provention Bio Inc () , Corbus Pharmaceuticals Holdings Inc () , and Celldex Therapeutics Inc () .
Click here to see the complete history of Avery W Catlin’s form 4 insider trades.
Insider Ownership Summary of Avery W Catlin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Provention Bio Inc | 2018-12-26 | director | |
| Corbus Pharmaceuticals Holdings Inc | 2017-05-11 | director | |
| Celldex Therapeutics Inc | 2015-11-23 | Sr. VP & CFO |
Avery W Catlin Latest Holdings Summary
Avery W Catlin currently owns a total of 3 stocks. Among these stocks, Avery W Catlin owns 20,000 shares of Provention Bio Inc (PRVB) as of December 26, 2018, with a value of $499,600 and a weighting of 76.9%. Avery W Catlin owns 2,341 shares of Celldex Therapeutics Inc (CLDX) as of November 23, 2015, with a value of $88,911 and a weighting of 13.69%. Avery W Catlin also owns 1,567 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) as of May 11, 2017, with a value of $61,129 and a weighting of 9.41%.
Latest Holdings of Avery W Catlin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRVB | Provention Bio Inc | 2018-12-26 | 20,000 | 24.98 | 499,600 |
| CLDX | Celldex Therapeutics Inc | 2015-11-23 | 2,341 | 37.98 | 88,911 |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2017-05-11 | 1,567 | 39.01 | 61,129 |
Holding Weightings of Avery W Catlin
Avery W Catlin Form 4 Trading Tracker
According to the SEC Form 4 filings, Avery W Catlin has made a total of 0 transactions in Provention Bio Inc (PRVB) over the past 5 years. The most-recent trade in Provention Bio Inc is the acquisition of 10,000 shares on December 26, 2018, which cost Avery W Catlin around $18,800.
According to the SEC Form 4 filings, Avery W Catlin has made a total of 0 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years. The most-recent trade in Celldex Therapeutics Inc is the sale of 1,667 shares on November 23, 2015, which brought Avery W Catlin around $450,000.
According to the SEC Form 4 filings, Avery W Catlin has made a total of 0 transactions in Corbus Pharmaceuticals Holdings Inc (CRBP) over the past 5 years. The most-recent trade in Corbus Pharmaceuticals Holdings Inc is the acquisition of 167 shares on May 11, 2017, which cost Avery W Catlin around $30,750.
Insider Trading History of Avery W Catlin
- 1
Avery W Catlin Trading Performance
GuruFocus tracks the stock performance after each of Avery W Catlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Avery W Catlin is -0.96%. GuruFocus also compares Avery W Catlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Avery W Catlin within 3 months outperforms 4 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Avery W Catlin's insider trading performs compared to the benchmark.
Performance of Avery W Catlin
Average Return
108.61%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.85 | -0.96 | 58.4 | 108.61 | 68.95 | 33.74 |
| Relative Return to S&P 500(%) | 6.77 | -3.93 | 52.96 | 96.68 | 57.03 | 20.18 |
Avery W Catlin Ownership Network
Ownership Network List of Avery W Catlin
Ownership Network Relation of Avery W Catlin
Avery W Catlin Owned Company Details
What does Provention Bio Inc do?
Who are the key executives at Provention Bio Inc?
Avery W Catlin is the director of Provention Bio Inc. Other key executives at Provention Bio Inc include 10 percent owner Sessa Capital (master), L.p. , director & 10 percent owner & Chief Scientific Officer Francisco Leon , and director & 10 percent owner & President and CEO Ashleigh Palmer .
Provention Bio Inc () Insider Trades Summary
Over the past 18 months, Avery W Catlin made no insider transaction in Provention Bio Inc (). Other recent insider transactions involving Provention Bio Inc () include a net sale of 299,617 shares made by Francisco Leon , a net sale of 5,190,549 shares made by Sessa Capital (master), L.p. , and a net sale of 100,000 shares made by Ashleigh Palmer .
In summary, during the past 3 months, insiders sold 0 shares of Provention Bio Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,594,666 shares of Provention Bio Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,594,666 shares.
Provention Bio Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Provention Bio Inc Insider Transactions
Avery W Catlin Mailing Address
Above is the net worth, insider trading, and ownership report for Avery W Catlin. You might contact Avery W Catlin via mailing address: 241 Central Street, Hingham Ma 02043.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
